These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11522363)

  • 1. Scale-up of a myoblast culture process.
    Boudreault P; Tremblay JP; Pépin MF; Garnier A
    J Biotechnol; 2001 Sep; 91(1):63-74. PubMed ID: 11522363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth characteristics of normal and dystrophic myoblasts in primary myoblast cultures.
    Cheng KF; Chuang YH; Her WY; Chen SC; Liu KM
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):31-8. PubMed ID: 8931342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.
    Rando TA; Blau HM
    J Cell Biol; 1994 Jun; 125(6):1275-87. PubMed ID: 8207057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Process development of human multipotent stromal cell microcarrier culture using an automated high-throughput microbioreactor.
    Rafiq QA; Hanga MP; Heathman TRJ; Coopman K; Nienow AW; Williams DJ; Hewitt CJ
    Biotechnol Bioeng; 2017 Oct; 114(10):2253-2266. PubMed ID: 28627713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of agitation rate on aggregation during beads-to-beads subcultivation of microcarrier culture of human mesenchymal stem cells.
    Takahashi I; Sato K; Mera H; Wakitani S; Takagi M
    Cytotechnology; 2017 Jun; 69(3):503-509. PubMed ID: 27352111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice.
    Caron NJ; Asselin I; Morel G; Tremblay JP
    Cell Transplant; 1999; 8(5):465-76. PubMed ID: 10580341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the RAG-1 as a suitable mouse model for mitochondrial DNA disease.
    Pye D; Watt DJ; Walker C; Lightowlers RN; Turnbull DM
    Neuromuscul Disord; 2004 May; 14(5):329-36. PubMed ID: 15099593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles.
    Bouchentouf M; Benabdallah BF; Bigey P; Yau TM; Scherman D; Tremblay JP
    Gene Ther; 2008 Mar; 15(6):404-14. PubMed ID: 18079754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of MyoD increases donor myoblast migration into host muscle.
    Smythe GM; Grounds MD
    Exp Cell Res; 2001 Jul; 267(2):267-74. PubMed ID: 11426945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary culture of chick embryo skeletal muscle on dextran microcarrier.
    Pawlowski R; Szigeti V; Loyd R; Przybylski RJ
    Eur J Cell Biol; 1984 Nov; 35(2):296-303. PubMed ID: 6083864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of myoblast culture and myoblast transfer therapy in dystrophic mice].
    Jong HJ; Chen SS; Chuang YH; Chen TJ
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Jul; 11(7):398-408. PubMed ID: 7650779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin alpha subunit ratios, cytoplasmic domains, and growth factor synergy regulate muscle proliferation and differentiation.
    Sastry SK; Lakonishok M; Thomas DA; Muschler J; Horwitz AF
    J Cell Biol; 1996 Apr; 133(1):169-84. PubMed ID: 8601606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro culture of primary human myoblasts by using the dextran microcarriers Cytodex3®.
    Rozwadowska N; Malcher A; Baumann E; Kolanowski TJ; Rucinski M; Mietkiewski T; Fiedorowicz K; Kurpisz M
    Folia Histochem Cytobiol; 2016; 54(2):81-90. PubMed ID: 27270505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
    Hodgetts SI; Grounds MD
    Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of two populations of myoblasts from porcine skeletal muscle.
    Blanton JR; Grant AL; McFarland DC; Robinson JP; Bidwell CA
    Muscle Nerve; 1999 Jan; 22(1):43-50. PubMed ID: 9883856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention by anti-LFA-1 of acute myoblast death following transplantation.
    Guérette B; Skuk D; Célestin F; Huard C; Tardif F; Asselin I; Roy B; Goulet M; Roy R; Entman M; Tremblay JP
    J Immunol; 1997 Sep; 159(5):2522-31. PubMed ID: 9278346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock pretreatment enhances porcine myoblasts survival after autotransplantation in intact skeletal muscle.
    Yang S; Laumonier T; Menetrey J
    Sci China C Life Sci; 2007 Aug; 50(4):438-46. PubMed ID: 17653663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Culture and function of electrofusion-derived clonal insulin-secreting cells immobilized on solid and macroporous microcarrier beads.
    Hamid M; McCluskey JT; McClenaghan NH; Flatt PR
    Biosci Rep; 2000 Jun; 20(3):167-76. PubMed ID: 11095116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solvent-free preparation of porous poly(l-lactide) microcarriers for cell culture.
    Kuterbekov M; Machillot P; Lhuissier P; Picart C; Jonas AM; Glinel K
    Acta Biomater; 2018 Jul; 75():300-311. PubMed ID: 29883812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.